Frank Pasqualone - Net Worth and Insider Trading
Frank Pasqualone Net Worth
The estimated net worth of Frank Pasqualone is at least $2 Million dollars as of 2024-11-29. Frank Pasqualone is the SVP, Chief Comm Ops Officer of Theravance Biopharma Inc and owns about 213,180 shares of Theravance Biopharma Inc (TBPH) stock worth over $2 Million. Frank Pasqualone is also the Director of Enveric Biosciences Inc and owns about 1,000 shares of Enveric Biosciences Inc (ENVB) stock worth over $326. Details can be seen in Frank Pasqualone's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Frank Pasqualone has not made any transactions after 2023-09-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Frank Pasqualone
Frank Pasqualone Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frank Pasqualone owns 3 companies in total, including Theravance Biopharma Inc (TBPH) , Innoviva Inc (INVA) , and Enveric Biosciences Inc (ENVB) .
Click here to see the complete history of Frank Pasqualone’s form 4 insider trades.
Insider Ownership Summary of Frank Pasqualone
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TBPH | Theravance Biopharma Inc | 2017-08-21 | Sr. Vice President & Operations |
| INVA | Innoviva Inc | 2014-01-13 | Sr. Vice President & Operations |
| ENVB | Enveric Biosciences Inc | 2023-09-15 | director |
Frank Pasqualone Latest Holdings Summary
Frank Pasqualone currently owns a total of 2 stocks. Among these stocks, Frank Pasqualone owns 213,180 shares of Theravance Biopharma Inc (TBPH) as of August 21, 2017, with a value of $2 Million and a weighting of 99.98%. Frank Pasqualone also owns 1,000 shares of Enveric Biosciences Inc (ENVB) as of September 15, 2023, with a value of $326 and a weighting of 0.02%.
Latest Holdings of Frank Pasqualone
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TBPH | Theravance Biopharma Inc | 2017-08-21 | 213,180 | 9.42 | 2,008,156 |
| ENVB | Enveric Biosciences Inc | 2023-09-15 | 1,000 | 0.33 | 326 |
Holding Weightings of Frank Pasqualone
Frank Pasqualone Form 4 Trading Tracker
According to the SEC Form 4 filings, Frank Pasqualone has made a total of 0 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years. The most-recent trade in Theravance Biopharma Inc is the acquisition of 4,000 shares on August 21, 2017, which cost Frank Pasqualone around $105,360.
According to the SEC Form 4 filings, Frank Pasqualone has made a total of 1 transactions in Enveric Biosciences Inc (ENVB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Enveric Biosciences Inc is the acquisition of 1,000 shares on September 15, 2023, which cost Frank Pasqualone around $2,140.
Insider Trading History of Frank Pasqualone
- 1
Frank Pasqualone Trading Performance
GuruFocus tracks the stock performance after each of Frank Pasqualone's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frank Pasqualone is -16.77%. GuruFocus also compares Frank Pasqualone's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frank Pasqualone within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frank Pasqualone's insider trading performs compared to the benchmark.
Performance of Frank Pasqualone
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.48 | | | | | |
| Relative Return to S&P 500(%) | 9.37 | | | | | |
Frank Pasqualone Ownership Network
Frank Pasqualone Owned Company Details
What does Theravance Biopharma Inc do?
Who are the key executives at Theravance Biopharma Inc?
Frank Pasqualone is the Sr. Vice President & Operations of Theravance Biopharma Inc. Other key executives at Theravance Biopharma Inc include SVP & Comm & Medical Affairs Rhonda Farnum , 10 percent owner Eli Samaha , and SVP & Development Richard A Graham .
Theravance Biopharma Inc (TBPH) Insider Trades Summary
Over the past 18 months, Frank Pasqualone made no insider transaction in Theravance Biopharma Inc (TBPH). Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include a net sale of 14,412 shares made by Richard A Graham , a net sale of 14,229 shares made by Rhonda Farnum , and a net purchase of 2,498,924 shares made by Eli Samaha .
In summary, during the past 3 months, insiders sold 4,000 shares of Theravance Biopharma Inc (TBPH) in total and bought 0 shares, with a net sale of 4,000 shares. During the past 18 months, 28,641 shares of Theravance Biopharma Inc (TBPH) were sold and 2,498,924 shares were bought by its insiders, resulting in a net purchase of 2,470,283 shares.
Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Theravance Biopharma Inc Insider Transactions
Frank Pasqualone Mailing Address
Above is the net worth, insider trading, and ownership report for Frank Pasqualone. You might contact Frank Pasqualone via mailing address: 901 Gateway Blvd, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
